Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for Chronic Hepatic Pruritus
NCT04256759Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2020
- Primary completion
- Sep 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in Pruritus Associated With Liver Disease, sponsored by Mayo Clinic. Started Sep 2020; status: completed.
02
Drugs
03
Conditions
Pruritus Associated With Liver Disease
Beyond the preview
Go deeper on NCT04256759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04256759.